You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ixekizumab

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)

Recruiting
  • Uveitis, Posterior
  • +3 more
  • Ixekizumab Prefilled Syringe
  • Waltham, Massachusetts
    Massachusetts Eye Research and Surgery Institution
Oct 11, 2023

Plaque Psoriasis Trial in Outram Park (Ixekizumab, Methotrexate, Cyclosporin A)

Recruiting
  • Plaque Psoriasis
  • Ixekizumab
  • +3 more
  • Outram Park, Singapore
    Singapore General Hospital
Nov 23, 2022

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

Recruiting
  • Psoriasis Vulgaris
  • Venapuncture
  • Patient questionnaires
  • Ghent, Oost-Vlaanderen, Belgium
  • +6 more
Jan 16, 2023

Pyoderma Gangrenosum Trial in Gahanna (Ixekizumab)

Completed
Has Results
  • Pyoderma Gangrenosum
  • Ixekizumab
  • Gahanna, Ohio
    The Ohio State University Dermatology
May 11, 2022

Plaque Psoriasis, Psoriatic Arthritis Trial in India (Ixekizumab)

Not yet recruiting
  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Ixekizumab
  • Raipur, Chhattisgarh, India
  • +14 more
May 4, 2023

Type1 Diabetes Trial in Sweden (Ixekizumab, Placebo)

Recruiting
  • Type1 Diabetes Mellitus
  • Ixekizumab
  • Placebo
  • Borås, Sweden
  • +17 more
Dec 5, 2022

Spondyloarthritis Trial in China (Ixekizumab, Placebo)

Completed
Has Results
  • Spondyloarthritis
  • Ixekizumab
  • Placebo
  • Bengbu, Anhui, China
  • +18 more
Jun 20, 2022

Immunoclassification, Psoriasis Trial in Hangzhou (adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors,

Recruiting
  • Immunoclassification
  • Psoriasis
  • adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 16, 2022

Idiopathic Subglottic Stenosis Trial in New Haven (Taltz)

Not yet recruiting
  • Idiopathic Subglottic Stenosis
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 21, 2022

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

Generalized Pustular Psoriasis, Erythrodermic Psoriasis Trial in Japan (Ixekizumab)

Completed
Has Results
  • Generalized Pustular Psoriasis
  • Erythrodermic Psoriasis
  • Ixekizumab
  • Nagoya, Aichi, Japan
  • +6 more
Jul 21, 2021

Plaque Psoriasis Trial (Ixekizumab+Jueyin Granules, Ixekizumab+Jueyin Granules)

Not yet recruiting
  • Plaque Psoriasis
  • Ixekizumab+Jueyin Granules
  • Ixekizumab+Jueyin placebo Granules
  • (no location specified)
Sep 4, 2021

MDD Trial in New York (Ixekizumab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Ixekizumab
  • Placebo
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 16, 2021

Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)

Recruiting
  • Psoriatic Arthritis
  • +2 more
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen
Nov 10, 2022

Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

Completed
  • Covid19
  • Ixekizumab
  • +3 more
  • Ribeirão Preto, SP, Brazil
  • +1 more
Jul 26, 2022

Healthy Trial in Dallas, Madison (Ixekizumab)

Completed
Has Results
  • Healthy
  • Ixekizumab
  • Dallas, Texas
  • +1 more
Nov 6, 2020

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Brussels, Belgium
  • +18 more
Dec 5, 2022

Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Birmingham, Alabama
  • +7 more
Sep 19, 2022

Plaque Psoriasis Trial in China (Ixekizumab, Placebo)

Completed
Has Results
  • Plaque Psoriasis
  • Ixekizumab
  • Placebo
  • Beijing, Beijing, China
  • +16 more
Jun 3, 2021

Healthy Trial in Daytona Beach (Ixekizumab)

Completed
Has Results
  • Healthy
  • Ixekizumab
  • Daytona Beach, Florida
    Covance Clinical Research Inc
Jun 5, 2020

Pityriasis Rubra Pilaris Trial in Portland (Ixekizumab)

Completed
Has Results
  • Pityriasis Rubra Pilaris
  • Ixekizumab
  • Portland, Oregon
    Oregon Health and Science University
Jun 15, 2020

Psoriasis Trial in Changsha, Hangzhou, Shanghai (Ixekizumab)

Completed
Has Results
  • Psoriasis
  • Ixekizumab
  • Changsha, Hunan, China
  • +2 more
Jul 17, 2020

Bullous Pemphigoid, Pemphigoid Trial in Scottsdale (Ixekizumab)

Completed
Has Results
  • Bullous Pemphigoid
  • Pemphigoid
  • Ixekizumab
  • Scottsdale, Arizona
    Mayo Clinic
May 11, 2020

Plaque Psoriasis Trial in Worldwide (Ixekizumab, Placebo, Etanercept)

Completed
Has Results
  • Plaque Psoriasis
  • Ixekizumab
  • +2 more
  • Birmingham, Alabama
  • +68 more
Aug 30, 2021

Plaque Psoriasis Trial in Worldwide (Risankizumab)

Active, not recruiting
  • Plaque Psoriasis
  • Phoenix, Arizona
  • +56 more
Mar 10, 2022